Dannis E Hood, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 132 Battlefield Crossing Ct, Ringgold, GA 30736 Phone: 706-858-3988 Fax: 706-858-9022 |
Dr. Timothy Mark Ashburn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4635 Battlefield Pkwy, Ringgold, GA 30736 Phone: 706-841-0833 Fax: 706-841-0020 |
Dr. Charles C Adams, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4085 Cloud Springs Rd, Ringgold, GA 30736 Phone: 706-861-7377 Fax: 706-861-7922 |
Salvador Bruno, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4750 Battlefield Pkwy, Ringgold, GA 30736 Phone: 706-866-0734 Fax: 706-866-0934 |
Dr. Dianne C Roland, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4700 Battlefield Pkwy, Suite 150, Ringgold, GA 30736 Phone: 706-861-2826 Fax: 706-861-2773 |
M Clark Colvard Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4700 Battlefield Pkwy, Ste 100, Ringgold, GA 30736 Phone: 706-806-0170 Fax: 706-806-0200 |
Dr. Terri L Jones, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 110 Battlefield Crossing Ct, Ringgold, GA 30736 Phone: 706-861-0004 Fax: 706-861-0050 |
News Archive
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A new study found that of the 19.5 percent of high school students who call themselves smokers, most don't smoke daily or frequently. Between 1991 and 2009, heavy smoking declined among public and private high school students, but light smoking increased, according to a national survey.
People could permanently damage their eyesight and even risk blindness if they look directly at Venus passing across the face of the Sun on June 8th warned the Government's Chief Medical Officer today as he offered eye-safe alternatives.
While the health risks associated with indoor secondhand smoke are well documented, little research has been done on exposure to toxic tobacco fumes outdoors.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
› Verified 2 days ago